An FDA panel recommends the Pfizer vaccine for kids ages 5 to 11

After some debate, a group of scientists advising the agency concluded that the vaccine's benefits outweigh its risks for young children.

An FDA panel recommends the Pfizer vaccine for kids ages 5 to 11 After some debate, a group of scientists advising the agency concluded that the vaccine's benefits outweigh its risks for young children. Read More You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002 Unsubscribe  |  Privacy Policy